This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report code 0050U for the MyAML™ NGS Panel by LabPMM LLC, an Invivoscribe Technologies, Inc., Company, which is a next–generation targeted sequencing (NGS) assay of 194 genes for sequence and copy number variants associated with acute myelogenous leukemia (AML).
For clinical responsibility, terminology, tips and additional info
start codify free trial.